MIRA
INFORM REPORT
|
Report Date : |
06.05.2011 |
IDENTIFICATION DETAILS
|
Name : |
CLINIQUE CASAHAUS |
|
|
|
|
Registered Office : |
BP 2102 |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
15.10.2001 |
|
|
|
|
Com. Reg. No.: |
80B7 |
|
|
|
|
Legal Form : |
Limited Liability Company, Limited by shares |
|
|
|
|
Line of Business : |
Distributors of
pharmaceutical products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
30,000 USD |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
REGISTERED NAME & COMPANY
SUMMARY
|
COMPANY REPORTED: |
CLINIQUE CASAHAUS |
|||
|
Other Names: |
CLINIQUE CASAHOUS |
|||
|
Principal Address: |
BP 2102 |
|||
|
Telephone: |
+221-33-8213030/ 3122/
6335251/ 8515436 |
|||
|
Fax: |
+221-33-8216671 |
|||
|
Email: |
None |
|||
|
Internet: |
None |
|||
|
Established: |
15/10/2001 |
|||
|
Registration: |
80B7 |
|||
|
Legal Form: |
Limited Liability
Company, Limited by shares |
|||
|
Stock Listing: |
Not Listed |
|||
|
Workforce: |
2010 |
|
|
|
|
|
30 |
|
|
|
|
Office & Factories |
|
|||
|
Head offices |
5 Rue De Thiong |
|||
|
Branches |
None |
|||
CREDIT RECOMENDATION
Current Credit Limit: 30,000 USD
DIRECTORS/MANAGEMENT
|
Management/ Directors |
|
|
President/ CEO (1) |
|
|
Name |
Dr.
Abdou Kane Diop |
|
Active in daily
business: |
Active |
|
Current Title: |
Director |
|
Country of residence |
|
|
Remarks |
Top Decision Maker |
|
Director (2) |
|
|
Name |
Dr.
Hussein Bahsoum |
|
Active in daily
business: |
Active |
|
Current Title: |
Director |
|
Country of residence |
|
̃
Top decision maker is the person
who has the ultimate authority or power to make important managerial decisions.
He/She may or may not be officially registered as a president or an executive
director.
NEGATIVE INFORMATION
No negative information found.
SHARE & SHARE CAPITAL INFORMATION
|
Company Profile: |
|
||
|
Nominal Capital |
CFA.
50,000,000 |
||
|
Shareholders |
|
||
|
Name |
Position |
Amount
|
Ratio |
|
Dr.
Abdou Kane Diop |
Director |
|
|
|
Dr.
Hussein Bahsoum |
Director |
|
|
|
Dr.
Hassan Bahsoum |
Director |
|
|
|
Total |
|
|
100.00% |
PAYMENT INFORMATION
|
|
Terms of payment |
|
Buying terms |
30% in cash, 70% on
credit |
|
Selling terms |
80% in cash, 20% on
credit |
|
|
|
|
Suppliers |
Various Companies |
|
Customers |
firms and organizations |
|
|
|
|
Recent Sales |
CFA. 3,874,000,000 (2010 Estimated) |
|
Exports |
None |
|
Export Ratio |
0.0% |
|
Import Ratio |
40.0% |
|
Domestic Market Share |
10.0% |
GROUP STRUCTURE & AFFILIATED
COMPANIES
|
Affiliated Companies |
None |
FINANCIAL INFORMATION
Na
FOREIGN EXCHANGE RATE
Na
ADDITIONAL INFORMATION
|
Business Activities |
Distributors
of pharmaceutical products |
|
|
Terms of payment |
|
Buying terms |
30% in cash, 70% on
credit |
|
Selling terms |
80% in cash, 20% on
credit |
|
|
|
|
Suppliers |
Various Companies |
|
Customers |
firms and organizations |
|
|
|
|
Recent Sales |
CFA. 3,874,000,000 (2010 Estimated) |
|
Exports |
None |
|
Export Ratio |
0.0% |
|
Import Ratio |
40.0% |
|
Domestic Market Share |
10.0% |
|
Business Premises |
2000 Sft |
|
Type of occupation
|
Leased |
|
Location |
The subject is located
close to a major road network |
|
Premises used as |
Offices |
|
Banking relationship |
|
|
Main Banks |
UBA bank |
NOTES & COMMENTS
Na
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.57 |
|
|
1 |
Rs.73.58 |
|
Euro |
1 |
Rs.66.23 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.